Faculty Information |
|
Article types | Original article |
Language | English |
Refereed paper | Refereed |
Title | Prognostic value of pretreatment volume-based quantitative (18)F-FDG PET/CT parameters in patients with malignant pleural mesothelioma. |
Journal | Formal name:European journal of radiology Abbreviation:Eur J Radiol ISSN code:1872-7727(Electronic)0720-048X(Linking) |
Domestic / Foregin | Foregin |
Volume, Number, Page | 86,pp.176-183 |
Papers・Author | Kitajima Kazuhiro, Doi Hiroshi, Kuribayashi Kozo, Hashimoto Masaki, Tsuchitani Tatsuya, Tanooka Masao, Fukushima Kazuhito, Nakano Takashi, Hasegawa Seiki, Hirota Shozo |
Publication date | 2017/01 |
Papers・Description | PURPOSE:To investigate the relationships between pretreatment volume-based quantitative (18)F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) parameters and overall survival (OS) in patients with malignant pleural mesothelioma (MPM).MATERIALS AND METHODS:We retrospectively reviewed data from 201 MPM patients, of whom 38 underwent surgical resection, and calculated the maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and total lesion glycolysis (TLG), including primary tumors and nodal or distant metastatic lesions, on pretreatment (18)F-FDG PET/CT. Relationships between clinicopathological factors (age, sex, performance status, European Organization for Research and Treatment of Cancer [EORTC]score, histological subtype, TNM stage, and treatment strategy), volume-based quantitative PET/CT parameters, and OS were evaluated using a Cox proportional hazards model and log-rank test.RESULTS:The median follow-up was 15 months (range, 1-96 months; median, 17 months). In a univariate analysis of all patients, older age (p<0.05), high EORTC score (p<0.001), non-epithelioid histological subtype (p<0.001), high T stage (p<0.001), positive N/M status (p<0.05, p<0.001), advanced TNM stage (p<0.001), non-surgical treatment (p<0.001), and high SUVmax (p<0.001), MTV (p<0.001), or TLG (p<0.001) were associated with significantly shorter OS. A multivariate analysis confirmed non-epithelioid subtype (hazard ratio [HR]: 1.69, 95% confidence interval [CI]: 1.14-2.48; p<0.05), non-surgical treatment (HR: 0.58, 95% CI: 0.34-0.95; p<0.05), and high TLG (HR: 1.97, 95% CI: 1.14-3.44; p<0.05) as independent negative predictors.CONCLUSIONS:Pretreatment volume-based quantitative (18)F-FDG PET/CT parameters, especially TLG, could serve as potential surrogate markers for MPM prognosis. |
DOI | 10.1016/j.ejrad.2016.11.019 |
PMID | 28027744 |